Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CS-7017 + Paclitaxel in Advanced Anaplastic Thyroid Cancer
NCT00603941Phase 2Terminated
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2008
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of efatutazone in anaplastic thyroid cancer (ATC), sponsored by Daiichi Sankyo Co., Ltd.. Started Jan 2008; status: terminated.
02
Drugs
efatutazone
03
Conditions
anaplastic thyroid cancer (ATC)
Beyond the preview
Go deeper on NCT00603941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00603941.